Drugs in lactation Source: LactMed

Misoprostol and Breastfeeding

Summary of use during lactation

Misoprostol is a prostaglandin E1 analogue. Prostaglandin E1 and other prostaglandins appear normally in colostrum and milk.[1] Because of the extremely low levels of misoprostol in breastmilk, amounts ingested by the infant are trivial and would not be expected to cause any adverse effects in breastfed infants. No special precautions are required.

Drug levels in milk and infant serum

After absorption, misoprostol is rapidly converted into misoprostol acid in the liver. Studies of misoprostol measure misoprostol acid in the colostrum or milk. Maternal Levels. Twenty women received misoprostol 600 mcg orally during the first 4 days postpartum. Twelve of them collected a total of 24 colostrum samples at various times during the first 5 hours after the dose. The average misoprostol concentration was highest in colostrum 1 hour after the dose at 20.9 ng/L. Average concentrations fell to 17.8 ng/L at 2 hours after the dose, 9.4 ng/L at 3 hours, 2.8 ng/L at 4 hours and <1 ng/L at 5 hours after the dose.[2] Ten women who averaged 3.9 days postpartum received a single oral dose of misoprostol 200 mcg. Milk samples were obtained from one breast from 0.5 to 5 hours after the dose. The mean and median peak milk levels were 7.6 and 3.6 ng/L, respectively, at 1.1 hours after the dose. In 2 women, the peak milk level occurred 2 hours after the dose. By 5 hours, the median milk level was 0.2 ng/L. The half-life in milk averaged 1.1 hours.[3] Infant Levels. Relevant published information was not found as of the revision date.

Effects in breastfed infants

Relevant published information was not found as of the revision date.

Effects on lactation and breastmilk

Relevant published information was not found as of the revision date.

Alternative drugs to consider

(Oxytocic) Ergonovine, Methylergonovine; (Ulcers) Famotidine, Nizatidine, Omeprazole, Pantoprazole

References

  1. ShimizuT YamashiroY YabutaK. Prostaglandin E1, E2, and F2 alpha in human milk and plasma. Biol Neonate 1992 61 222 5 1610950 PubMed
  2. Abdel-AleemH VillarJ GulmezogluAM The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. Eur J Obstet Gynecol Reprod Biol 2003 108 25 8 12694965 PubMed
  3. VogelD BurkhardtT RentschK Misoprostol versus methylergometrine: Pharmacokinetics in human milk. Am J Obstet Gynecol 2004 191 2168 73 15592308 PubMed

Source: Drugs and Lactation Database (LactMed®), National Institute of Child Health and Human Development, NCBI Bookshelf. Check LactMed for the most recent revision.

Medical disclaimer: This page is for qualified healthcare professionals and is a decision-support aid only. It does not replace clinical judgement, local protocols or product information. Verify every dose and threshold before use. See the full Medical Disclaimer.